Dysfunctional chemosensation in myasthenia gravis: A systematic review

Journal of Clinical Neuromuscular Disease

Volumn 15, Issue 1, 2013, Pages 1-6

  Leon Sarmiento, Fidias E ^a,b   Leon Ariza, Daniel S ^c,d   Doty, Richard L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^c UNIVERSIDAD DE SANTANDER   (Colombia)

^d Neuronet Unicolciencias   (Colombia)

Author keywords

Alzheimer disease; myasthenia gravis; Parkinson disease; smell; taste

Indexed keywords

AGEUSIA; ARTICLE; CENTRAL NERVOUS SYSTEM; DATA EXTRACTION; DATA SYNTHESIS; HUMAN; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; ODOR; PRIORITY JOURNAL; SENSORY SYSTEM; SYSTEMATIC REVIEW; TASTE;

HUMANS; MYASTHENIA GRAVIS; OLFACTION DISORDERS; TASTE DISORDERS;

EID: 84883624291     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e31829e22ba     Document Type: Article

References (50)

1. Viets HR. A historical review of myasthenia gravis from 1672 to 1900. JAMA. 1953; 153: 1273-1280.
2. Carr AS, Cardwell CR, McCarron P.O., et al A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010; 10: 46.
3. Steiner I, Brenner T, Soffer D., et al Involvement of sites other than the neuromuscular junction in myas-thenia gravis. In: Lisak RP, ed. Handbook of Myasthe-nia Gravis and Myasthenic Syndromes. New York, NY: Marcel Dekker; 1994: 277-294.
4. Leon-Sarmiento F.E., Bayona EA, Bayona-Prieto J, et al Profound olfactory dysfunction in myasthenia gravis. PLoS One. 2012; 7:e45544.
5. Engel AG. Myasthenia Gravis and Myasthenic Syndromes. 2nd ed. New York, NY: Oxford University Press; 2012.
6. Pradilla G, Leon FE, Guevara G.M., et al Myasthenia gravis in the childhood. Acta Pediat Col. 1983; 1: 7-14.
7. Leon F. Myasthenia gravis beginning during pregnancy, partum or puerperium: a distinct clinical entity. Invest Clin. 1995; 36: 99-100.
8. Leon-S FE, Pradilla G., Guevara GM Myasthenia gravis and pregnancy. Acta Neurol Col. 1996; 12: 38-45.
9. Leon-Sarmiento F.E., Cotes de AF. Chronic myasthenia gravis mimicking muscular dystrophy, in eastern Colombia. Rev Neurol. 2001; 32: 145-147.
10. Conti-Fine B.M., Milani M, Kaminski HJ Myasthenia gravis: past, present, and future. J Clin Invest. 2006; 116: 2843-2854. (Pubitemid 44684466)
11. Meriggioli MN, Sanders DB Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009; 8: 475-490.
12. Oh SJ. Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status. J Clin Neurol. 2009; 5: 53-64.
13. Vincent A, McConville J, Farrugia M.E., et al Antibodies in myasthenia gravis and related disorders. Ann N Y Acad Sci. 2003; 998: 324-335. (Pubitemid 37194175)
14. Hughes T. The early history of myasthenia gravis. Neuromuscul Dis. 2005; 15: 878-886. (Pubitemid 41713144)
15. Tartara A, Mola M, Manni R., et al EEG findings in 118 cases of myasthenia gravis. Rev Electroencephalogr Neurophysiol Clin. 1982; 12: 275-279. (Pubitemid 13250760)
16. Kazis A, Pappa P, Xafenias D. EEG finding in myas-thenia gravis. Electromyogr Clin Neurophysiol. 1984; 24: 577-582.
17. Bohbot VD, Jech R, Bures J., et al Spatial and non-spatial memory involvement in myasthenia gravis. J Neurol. 1997; 244: 529-532. (Pubitemid 27424794)
18. Tucker DM, Roeltgen DP, Wann P.D., et al Memory dysfunction in myasthenia gravis: evidence for central cholinergic effects. Neurology. 1988; 38: 1173-1177.
19. Patten BM. Myasthenia gravis: review of diagnosis and management. Muscle Nerve. 1978: 1: 190-205.
20. Alajouanine T, Castaigne P, Nick J., et al The existence of sensitive and sensorial signs in myasthenia. Rev Neurol. 1957; 340-343.
21. Musha M, Tanaka F, Ohuti M. Psychoses in three cases with myasthenia gravis and thymoma-proposal of a paraneoplastic autoimmune neuropsychiatric syndrome. Tohoku J Exp Med. 1993; 169: 335-344.
22. Doty RL, Shaman P, Applebaum S.L., et al Smell identification ability: changes with age. Science.s 1984; 226: 1441-1443. (Pubitemid 15161278)
23. Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav. 1984; 32: 489-502. (Pubitemid 14148126)
24. Doty RL. Olfactory dysfunction in Parkinson disease. Nat Rev Neurol. 2012; 8: 329-339.
25. Dalakas MC. Polymyositis and Dermatomyositis. Boston, MA: Butterworth, 1987.
26. Jacob A, Clack ER, Emery AE Genetic study of sample of 70 patients with myasthenia gravis. J Med Genet. 1968; 5: 257-261.
27. Guo SW, Reed DR The genetics of phenylthiocarba-mide perception. Ann Hum Biol. 2001; 28: 111-142.
28. Kabasawa C, Shimizu Y, Suzuki S., et al Taste disorders in myasthenia gravis: a multicenter cooperative study. Eur J Neurol. 2013; 20: 205-207.
29. Sera I, Shibayama K, Motomura M., et al A 46-year-old woman with myasthenia gravis associated with macro-mastia, erythroderma and hypogeusia [in Japanese]. Rinsho Shinkeigaku. 1994; 34: 77-79. (Pubitemid 24135388)
30. Kanzato N, Ohta M, Kuniyoshi M., et al A patient with intractable myasthenia gravis successfully treated with total lymphoid irradiation [in Japanese]. Rinsho Shinkeigaku. 1999; 39: 757-762. (Pubitemid 29507925)
31. Takamori S, Hayashi A, Tayama K., et al Improvement of dysgeusia after thymectomy with thymoma. Kurume Med J. 1999; 46: 117-118.
32. Iseki K, Mezaki T, Kawamoto Y., et al Concurrence of non-myasthenic symptoms with myasthenia gravis. Neurol Sci. 2007; 28: 114-115. (Pubitemid 46681670)
33. Nakazato Y, Ito Y, Naito S., et al Dysgeusia limited to sweet taste in myasthenia gravis. Intern Med. 2008; 47: 877-878. (Pubitemid 351936210)
34. Hellier JL, Arevalo NL, Blatner M.J., et al Olfactory discrimination varies in mice with different levels of a7-nicotinic acetylcholine receptor expression. Brain Res. 2010; 1358: 140-150.
35. Doty RL, Bagla R, Kim N. Physostigmine enhances performance on an odor mixture discrimination test. Physiol Behav. 1999; 65: 801-804. (Pubitemid 29094718)
36. Ang L-H, Chen W., Yao Y, et al Lim kinase regulates the development of olfactory and neuromuscular synapses. Dev Biol. 2006; 293: 178-190. (Pubitemid 44316548)
37. Serby M, Flicker C, Rypma B., et al Scopolamine and olfactory function. Biol Psychiatry. 1990; 28: 79-82. (Pubitemid 20210887)
38. Ogura T, Margolskee RF, Tallini Y.N., et al Immuno-localization of vesicular acetylcholine transporter in mouse taste cells and adjacent nerve fibers: indication of acetylcholine release. Cell Tissue Res. 2007; 330: 17-28. (Pubitemid 47438595)
39. Ogura T. Acetylcholine increases intracellular Ca2+ in taste cells via activation of muscarinic receptors. J Neurophysiol. 2002; 87: 2643-2649. (Pubitemid 34670644)
40. Landgren S, Liljestrand G, Zotterman Y. Chemical transmission in taste fibre endings. Acta Physiol Scand. 1954; 30: 105-114.
41. Garcia-Perez MA. Is the DeVries-Rose to Weber transition empirically possible with sine-wave gratings? Span J Psychol. 2005; 8: 113-118. (Pubitemid 41501317)
42. Hasegawa K, Ogawa H. Effects of acetylcholine on coding of taste information in the primary gustatory cortex in rats. Exp Brain Res. 2007; 179: 97-109. (Pubitemid 46659224)
43. Ogura T, Lin W. Acetylcholine and acetylcholine receptors in taste receptor cells. Chem Senses. 2005; 30 Suppl 1)::i41.
44. Oliveira-Maia A.J., Stapleton-Kotloski JR, Lyall V., et al Nicotine activates TRPM5-dependent and independent taste pathways. Proc Natl Acad Sci U S A. 2009; 106: 1596-1601.
45. Burdach K, Doty RL Retronasal flavor perception: Influences of mouth movements, swallowing and spitting. Physiol Behav. 1987; 41: 353-356. (Pubitemid 18048058)
46. Cowan PW. Atrophy of fungiform papillae following lingual nerve damage - A suggested mechanism. Br Dent J. 1990; 168: 95.
47. Claussen GC, Fsenmeier JT, Smith K.E., et al Diagnostic value of the facial repetitive nerve stimulation test in myasthenia gravis. Muscle Nerve. 1993; 16: 1090-1091.
48. De Assis J.L., Marchiori PE, Scaff M. Atrophy of the tongue with persistent articulation disorder in myas-thenia gravis: report of 10 patients. Auris Nasus Larynx. 1994; 21: 215-218.
49. Farrugia ME, Robson MD, Clover L, et al MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain. 2006; 129: 1481-1492. (Pubitemid 43999381)
50. Doty RL, Bromley SM Effects of drugs on olfaction and taste. Otolaryngol Clin North Am. 2004; 37: 1229-1254. (Pubitemid 39572504)